Allarity Therapeutics Initiates Phase 2 Trial of IXEMPRA® in Europe for the Treatment of Metastatic Breast Cancer

    NEXT STORY
    Global Liver Institute Offering Multilingual Materials and Grants for International NASH Day on June 10
    PREV STORY
    Herborium® Group Inc. Skin Health Products to Enter $250 Million Pacific Asian Market
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Point-of-Care Diagnostics Market for Infectious Diseases, 2020-2025

    author_avatar
    NASDAQ Market News

    GW Pharmaceuticals Announces Research & Development Management Appointments

    – Dr. Volker Knappertz appointed Chief Medical Officer –– Professor Ben Whalley to join ...

    author_avatar
    NASDAQ Market News

    Iterum Therapeutics Announces Expiration and Preliminary Results of Rights Offering

    author_avatar
    NASDAQ Market News